Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.

<h4>Background</h4>Elucidating the role of the underlying risk factors for severe outcomes of the 2009 A/H1N1 influenza pandemic could be crucial to define priority risk groups in resource-limited settings in future pandemics.<h4>Methods</h4>We use individual-level clinical d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gerardo Chowell, Santiago Echevarría-Zuno, Cécile Viboud, Lone Simonsen, Mark A Miller, Irma Fernández-Gárate, Cesar González-Bonilla, Víctor H Borja-Aburto
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/26fb4315b01445798f1352e4d2aa5b05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26fb4315b01445798f1352e4d2aa5b05
record_format dspace
spelling oai:doaj.org-article:26fb4315b01445798f1352e4d2aa5b052021-11-18T07:12:19ZEpidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.1932-620310.1371/journal.pone.0041069https://doaj.org/article/26fb4315b01445798f1352e4d2aa5b052012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22815917/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Elucidating the role of the underlying risk factors for severe outcomes of the 2009 A/H1N1 influenza pandemic could be crucial to define priority risk groups in resource-limited settings in future pandemics.<h4>Methods</h4>We use individual-level clinical data on a large series of ARI (acute respiratory infection) hospitalizations from a prospective surveillance system of the Mexican Social Security medical system to analyze clinical features at presentation, admission delays, selected comorbidities and receipt of seasonal vaccine on the risk of A/H1N1-related death. We considered ARI hospitalizations and inpatient-deaths, and recorded demographic, geographic, and medical information on individual patients during August-December, 2009.<h4>Results</h4>Seasonal influenza vaccination was associated with a reduced risk of death among A/H1N1 inpatients (OR = 0.43 (95% CI: 0.25, 0.74)) after adjustment for age, gender, geography, antiviral treatment, admission delays, comorbidities and medical conditions. However, this result should be interpreted with caution as it could have been affected by factors not directly measured in our study. Moreover, the effect of antiviral treatment against A/H1N1 inpatient death did not reach statistical significance (OR = 0.56 (95% CI: 0.29, 1.10)) probably because only 8.9% of A/H1N1 inpatients received antiviral treatment. Moreover, diabetes (OR = 1.6) and immune suppression (OR = 2.3) were statistically significant risk factors for death whereas asthmatic persons (OR = 0.3) or pregnant women (OR = 0.4) experienced a reduced fatality rate among A/H1N1 inpatients. We also observed an increased risk of death among A/H1N1 inpatients with admission delays >2 days after symptom onset (OR = 2.7). Similar associations were also observed for A/H1N1-negative inpatients.<h4>Conclusions</h4>Geographical variation in identified medical risk factors including prevalence of diabetes and immune suppression may in part explain between-country differences in pandemic mortality burden. Furthermore, access to care including hospitalization without delay and antiviral treatment and are also important factors, as well as vaccination coverage with the 2008-09 trivalent inactivated influenza vaccine.Gerardo ChowellSantiago Echevarría-ZunoCécile ViboudLone SimonsenMark A MillerIrma Fernández-GárateCesar González-BonillaVíctor H Borja-AburtoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 7, p e41069 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gerardo Chowell
Santiago Echevarría-Zuno
Cécile Viboud
Lone Simonsen
Mark A Miller
Irma Fernández-Gárate
Cesar González-Bonilla
Víctor H Borja-Aburto
Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
description <h4>Background</h4>Elucidating the role of the underlying risk factors for severe outcomes of the 2009 A/H1N1 influenza pandemic could be crucial to define priority risk groups in resource-limited settings in future pandemics.<h4>Methods</h4>We use individual-level clinical data on a large series of ARI (acute respiratory infection) hospitalizations from a prospective surveillance system of the Mexican Social Security medical system to analyze clinical features at presentation, admission delays, selected comorbidities and receipt of seasonal vaccine on the risk of A/H1N1-related death. We considered ARI hospitalizations and inpatient-deaths, and recorded demographic, geographic, and medical information on individual patients during August-December, 2009.<h4>Results</h4>Seasonal influenza vaccination was associated with a reduced risk of death among A/H1N1 inpatients (OR = 0.43 (95% CI: 0.25, 0.74)) after adjustment for age, gender, geography, antiviral treatment, admission delays, comorbidities and medical conditions. However, this result should be interpreted with caution as it could have been affected by factors not directly measured in our study. Moreover, the effect of antiviral treatment against A/H1N1 inpatient death did not reach statistical significance (OR = 0.56 (95% CI: 0.29, 1.10)) probably because only 8.9% of A/H1N1 inpatients received antiviral treatment. Moreover, diabetes (OR = 1.6) and immune suppression (OR = 2.3) were statistically significant risk factors for death whereas asthmatic persons (OR = 0.3) or pregnant women (OR = 0.4) experienced a reduced fatality rate among A/H1N1 inpatients. We also observed an increased risk of death among A/H1N1 inpatients with admission delays >2 days after symptom onset (OR = 2.7). Similar associations were also observed for A/H1N1-negative inpatients.<h4>Conclusions</h4>Geographical variation in identified medical risk factors including prevalence of diabetes and immune suppression may in part explain between-country differences in pandemic mortality burden. Furthermore, access to care including hospitalization without delay and antiviral treatment and are also important factors, as well as vaccination coverage with the 2008-09 trivalent inactivated influenza vaccine.
format article
author Gerardo Chowell
Santiago Echevarría-Zuno
Cécile Viboud
Lone Simonsen
Mark A Miller
Irma Fernández-Gárate
Cesar González-Bonilla
Víctor H Borja-Aburto
author_facet Gerardo Chowell
Santiago Echevarría-Zuno
Cécile Viboud
Lone Simonsen
Mark A Miller
Irma Fernández-Gárate
Cesar González-Bonilla
Víctor H Borja-Aburto
author_sort Gerardo Chowell
title Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
title_short Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
title_full Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
title_fullStr Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
title_full_unstemmed Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.
title_sort epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in mexico.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/26fb4315b01445798f1352e4d2aa5b05
work_keys_str_mv AT gerardochowell epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT santiagoechevarriazuno epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT cecileviboud epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT lonesimonsen epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT markamiller epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT irmafernandezgarate epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT cesargonzalezbonilla epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
AT victorhborjaaburto epidemiologicalcharacteristicsandunderlyingriskfactorsformortalityduringtheautumn2009pandemicwaveinmexico
_version_ 1718423776963592192